Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors.

Haugvik SP, Labori KJ, Waage A, Line PD, Mathisen Ø, Gladhaug IP.

J Gastrointest Surg. 2013 Jul;17(7):1224-32. doi: 10.1007/s11605-013-2221-6. Epub 2013 May 14. Review.

PMID:
23670519
2.

Long-term outcome of laparoscopic surgery for pancreatic neuroendocrine tumors.

Haugvik SP, Marangos IP, Røsok BI, Pomianowska E, Gladhaug IP, Mathisen O, Edwin B.

World J Surg. 2013 Mar;37(3):582-90. doi: 10.1007/s00268-012-1893-5.

PMID:
23263686
3.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
4.

En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL.

J Gastrointest Surg. 2002 Mar-Apr;6(2):147-57; discussion 157-8.

PMID:
11992799
5.

Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.

Birnbaum DJ, Turrini O, Vigano L, Russolillo N, Autret A, Moutardier V, Capussotti L, Le Treut YP, Delpero JR, Hardwigsen J.

Ann Surg Oncol. 2015 Mar;22(3):1000-7. doi: 10.1245/s10434-014-4016-8. Epub 2014 Sep 5.

PMID:
25190116
6.

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

Fernández-Cruz L, Blanco L, Cosa R, Rendón H.

World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2.

PMID:
18264824
7.

En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.

Yekebas EF, Bogoevski D, Cataldegirmen G, Kunze C, Marx A, Vashist YK, Schurr PG, Liebl L, Thieltges S, Gawad KA, Schneider C, Izbicki JR.

Ann Surg. 2008 Feb;247(2):300-9. doi: 10.1097/SLA.0b013e31815aab22.

PMID:
18216537
8.

Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?

Teh SH, Deveney C, Sheppard BC.

Am J Surg. 2007 May;193(5):610-3; discussion 613.

PMID:
17434366
9.

Therapeutic Strategies for Advanced Pancreatic Neuroendocrine Tumors with Segmental Portal Hypertension.

Dumont F, Goudard Y, Caramella C, Goéré D, Baudin E, Elias D.

World J Surg. 2015 Aug;39(8):1974-80. doi: 10.1007/s00268-015-3030-8.

PMID:
25804547
10.

Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.

de Mestier L, Gaujoux S, Cros J, Hentic O, Vullierme MP, Couvelard A, Cadiot G, Sauvanet A, Ruszniewski P, Richard S, Hammel P.

Ann Surg. 2015 Aug;262(2):384-8. doi: 10.1097/SLA.0000000000000856.

PMID:
25185468
11.

Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?

Sallinen V, Haglund C, Seppänen H.

Surgery. 2015 Dec;158(6):1556-63. doi: 10.1016/j.surg.2015.04.035. Epub 2015 Jun 10.

PMID:
26070847
12.

Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.

Kondo NI, Ikeda Y, Maehara S, Sugimoto R, Nishiyama K, Sakaguchi Y.

JOP. 2013 Jul 10;14(4):415-22. doi: 10.6092/1590-8577/1291.

13.

Robotic extended pancreatectomy with vascular resection for locally advanced pancreatic tumors.

Giulianotti PC, Addeo P, Buchs NC, Ayloo SM, Bianco FM.

Pancreas. 2011 Nov;40(8):1264-70. doi: 10.1097/MPA.0b013e318220e3a4.

PMID:
21785385
14.

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.

Ito H, Abramson M, Ito K, Swanson E, Cho N, Ruan DT, Swanson RS, Whang EE.

J Gastrointest Surg. 2010 May;14(5):891-8. doi: 10.1007/s11605-010-1173-3. Epub 2010 Mar 12.

PMID:
20224984
15.

Laparoscopic resection of pancreatic neuroendocrine tumors.

Al-Kurd A, Chapchay K, Grozinsky-Glasberg S, Mazeh H.

World J Gastroenterol. 2014 May 7;20(17):4908-16. doi: 10.3748/wjg.v20.i17.4908. Review.

16.

Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.

Wong J, Fulp WJ, Strosberg JR, Kvols LK, Centeno BA, Hodul PJ.

Am J Surg. 2014 Nov;208(5):775-80. doi: 10.1016/j.amjsurg.2014.04.003. Epub 2014 Jun 8.

PMID:
24997491
17.

Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.

Poultsides GA, Huang LC, Chen Y, Visser BC, Pai RK, Jeffrey RB, Park WG, Chen AM, Kunz PL, Fisher GA, Norton JA.

Ann Surg Oncol. 2012 Jul;19(7):2295-303. doi: 10.1245/s10434-012-2305-7. Epub 2012 Mar 7.

PMID:
22396008
18.

Necrosis and angioinvasion predict adverse outcome in pancreatic neuroendocrine tumors after curative surgical resection: results of a single-center series.

Demir R, Pohl J, Agaimy A, Peros G, Perrakis A, Merkel S, Hohenberger W, Klein P.

World J Surg. 2011 Dec;35(12):2764-72. doi: 10.1007/s00268-011-1262-9.

PMID:
21927963
19.

Extended surgery for advanced pancreatic endocrine tumours.

Kleine M, Schrem H, Vondran FW, Krech T, Klempnauer J, Bektas H.

Br J Surg. 2012 Jan;99(1):88-94. doi: 10.1002/bjs.7681. Epub 2011 Aug 30.

PMID:
22135173
20.

Cytoreductive surgery in advanced endocrine tumours of the pancreas.

Pederzoli P, Falconi M, Bonora A, Salvia R, Sartori N, Contro C, Marcucci S, Bassi C.

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S207-12.

PMID:
10604132
Items per page

Supplemental Content

Write to the Help Desk